Trials / Not Yet Recruiting
Not Yet RecruitingNCT07442500
Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 470,000 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Studies exploring the feasibility of drug-eluting balloon (DCB) in de-novo coronary lesions are limited. There are scarce data comparing DCB with drug-eluting stent (DES) in patients with high bleeding risk (HBR), a situation in which long-term maintenance of dual antiplatelet therapy (DAPT) is a clinical dilemma. This target trial emulation aims to compare clinical outcomes between DCB angioplasty and conventional DES implantation in de-novo coronary lesions in patients with coronary artery disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Drug coated balloon | Patients receiving drug coated balloon angioplasty for de novo coronary artery disease |
| DEVICE | Drug-eluting stent | Patients receiving drug-eluting stent implantationfor de novo coronary artery disease |
Timeline
- Start date
- 2026-02-28
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
- First posted
- 2026-03-02
- Last updated
- 2026-03-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07442500. Inclusion in this directory is not an endorsement.